These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39121921)

  • 21. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone.
    Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro-In Vivo Correlation of Buprenorphine Transdermal Systems Under Normal and Elevated Skin Temperature.
    Thomas S; Hammell DC; Hassan HE; Stinchcomb AL
    Pharm Res; 2023 May; 40(5):1249-1258. PubMed ID: 37095369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
    Mohammed YH; Namjoshi SN; Jung N; Windbergs M; Benson HAE; Grice JE; Raney SG; Roberts MS
    Pharm Res; 2024 Jul; 41(7):1507-1520. PubMed ID: 38955999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model.
    Arora S; Clarke J; Tsakalozou E; Ghosh P; Alam K; Grice JE; Roberts MS; Jamei M; Polak S
    Mol Pharm; 2022 Sep; 19(9):3139-3152. PubMed ID: 35969125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An advanced automation platform coupled with mass spectrometry for investigating in vitro human skin permeation of UV filters and excipients in sunscreen products.
    Zhang J; Yang Y; Ashraf M; Cruz CN; Lee S; Faustino PJ
    Rapid Commun Mass Spectrom; 2022 Jun; 36(11):e9273. PubMed ID: 35178789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming the skin permeation barrier: challenges and opportunities.
    Vitorino C; Sousa J; Pais A
    Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innovations in transdermal drug delivery: formulations and techniques.
    Tiwary AK; Sapra B; Jain S
    Recent Pat Drug Deliv Formul; 2007; 1(1):23-36. PubMed ID: 19075872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
    Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
    J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
    Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
    Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discussion of EMA Draft Guideline on Quality and Equivalence of Topical Products Based on Comparison of Approved Mometasone Furoate Drugs.
    Eichner A; Mrestani Y; Hukauf M; Wohlrab J
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2153-2169. PubMed ID: 38997617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the in vitro permeation of 3-O-ethyl-l-ascorbic acid in human skin and in a living skin equivalent (LabSkin™).
    Iliopoulos F; Chapman A; Lane ME
    Int J Cosmet Sci; 2021 Feb; 43(1):107-112. PubMed ID: 33238056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling.
    Pensado A; Hattam L; White KAJ; McGrogan A; Bunge AL; Guy RH; Delgado-Charro MB
    Mol Pharm; 2021 Jul; 18(7):2714-2723. PubMed ID: 34124907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of synthetic membranes in establishing bio-predictive IVPT for testosterone transdermal gel.
    Mohamed LA; Kamal N; Elfakhri KH; Ibrahim S; Ashraf M; Zidan AS
    Int J Pharm; 2020 Aug; 586():119572. PubMed ID: 32599131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.
    Lehman PA; Franz TJ
    Pharm Res; 2014 Dec; 31(12):3529-37. PubMed ID: 25005736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro-In Vivo Correlation in Dermal Delivery: The Role of Excipients.
    Patel A; Iliopoulos F; Caspers PJ; Puppels GJ; Lane ME
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of excised human skin to assess the bioequivalence of topical products.
    Franz TJ; Lehman PA; Raney SG
    Skin Pharmacol Physiol; 2009; 22(5):276-86. PubMed ID: 19707043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vesicles: a recently developed novel carrier for enhanced topical drug delivery.
    Akhtar N
    Curr Drug Deliv; 2014; 11(1):87-97. PubMed ID: 24533724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.